Kimberly Guinan (K Guinan)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Combination Therapy

Ejection Fraction

Top Venues

Current oncology (Toronto, Ont.)

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Lachaine Jean, Kimberly Guinan, Andrew Aw, Versha Banerji, Isabelle Fleury, Carolyn Owen
Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada. Current oncology (Toronto, Ont.) 30 (5) (2023)
Kimberly Guinan, Karine Mathurin, Yunghan Au, Andre C Schuh, Cat N Bui, Xinglei Chai, Jean Lachaine
Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis. Current oncology (Toronto, Ont.) 29 (10) (2022)
Jean Lachaine, Catherine Beauchemin, Kimberly Guinan, Philippe Thebault, Andrew Aw, Versha Banerji, Isabelle Fleury, Carolyn Owen
Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada. Current oncology (Toronto, Ont.) 28 (1) (2021)
Catherine Beauchemin, Kimberly Guinan, D Claveau, Simon Frédéric Dufresne, Coleman Rotstein
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada. Expert review of pharmacoeconomics & outcomes research (2021)